Kite Pharma Acquires Interius BioTherapeutics for $350 Million to Boost CAR Therapy Platform
On August 22, 2025, Kite Pharma, Inc., a subsidiary of Gilead Sciences (NASDAQ: GILD), announced...
Deals
Bio-Thera Inks EUR 136m Deal with STADA for BAT1806 Commercialization
On August 21, 2025, Bio-Thera Solutions, Ltd. (SHA: 688177) announced a license and commercialization agreement...
3D Medicines and CATUG Biotech Forge Strategic Alliance in mRNA-LNP Innovation
China-based 3D Medicines (HKG: 1244) has entered into a strategic cooperation framework agreement with CATUG Biotechnology....
Abbisko’s ABSK043 Gains IND Approval for KRAS G12C NSCLC in Partnership with Allist
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that the Center for Drug Evaluation...
Haohai Biotech Terminates OK Lens Distribution Deal with Brighten Optix Amid Carl Zeiss Acquisition
Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826, SHA: 688366) announced the termination of its...
Nanjing Zenshine Pharma Partners with Cigalah Medpharm to Advance Sebaloxavir Marboxil in MENA
On August 21, 2025, Nanjing Zenshine Pharmaceuticals Co., Ltd, a China-based developer of small molecule...
Santhera Pharmaceuticals Signs Exclusive Agreement with Uniphar for AGAMREE Distribution in Middle East
Swiss firm Santhera Pharmaceuticals (SWX: SANN), a leader in innovative therapies for rare diseases, has...
Vivatides Therapeutics Completes Multi-Million Dollar Seed Financing to Advance Nucleic Acid Delivery Platform
Biopharmaceutical company Vivatides Therapeutics has successfully completed a multi-million dollar seed round financing led by...
Hunan FangSheng Pharmaceutical to Acquire JAK Inhibitor Patent Rights for RMB 80 Million
Hunan FangSheng Pharmaceutical Co., Ltd. (SHA: 603998) announced today that it has reached an agreement...
XtalPi Collaborates with Dong-A ST on AI-Driven Drug Discovery for Immunological Diseases
Shenzhen-based QuantumPharm Inc., known as Xtalpi Inc. (HKG: 2228) and Korea’s leading pharmaceutical company, Dong-A...
GoodRx and Novo Nordisk Introduce $499 Monthly Pricing for Semaglutide Pens
Goodrx Holdings Inc (NASDAQ: GDRX), the leading platform for medication savings in the U.S., has...
Genentech to End $2B Collaboration With Adaptive Biotechnologies on T-Cell Therapies
Genentech, a member of the Roche Group (SWX: ROG, OTCMKTS: RHHBY), will terminate its strategic...
Henlius Partners with GeneQuantum on HER2-Targeted ADC GQ1005 Development
Shanghai Henlius Biotech Inc. (HKG: 2696) announced a strategic collaboration with China-based GeneQuantum Healthcare. The...
Skyhawk Therapeutics Collaborates with Merck on RNA-Targeting Small Molecules for Neurological Diseases
Skyhawk Therapeutics, Inc. announced on August 18, 2025, a strategic research collaboration with Merck KGaA...
Ajinomoto and Amphastar Ink Licensing Pact for Oncology and wAMD Drug Candidates
Nanjing Ajinomoto Bio-Pharma Services and Amphastar Pharmaceuticals (NASDAQ: AMPH) announced on August 12, 2025, the...
FosunInsightec and Shanghai International Medical Center Establish National Focused Ultrasound Demonstration Center
FosunInsightec partnered with the Shanghai International Medical Center (SIMC) on August 11, 2025, to establish...
Minghui Pharmaceutical Secures $131M Pre-IPO Funding Led by OrbiMed and Qiming Ventures
China-based Minghui Pharmaceutical Inc. announced the successful completion of a $131 million Pre-IPO financing round....
Shanghai Pharmaceuticals and Baxter China Forge Strategic Partnership for Anesthesia Products
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, HKG: 2607, SHA: 601607) announced the signing of a...
Superluminal Collaborates With Eli Lilly on Small Molecule Therapeutics for Cardiometabolic Diseases
Superluminal Medicines announced on August 14, 2025, a collaboration with Eli Lilly (NYSE: LLY) to...
Fosun Pharma Issues China’s First Private Pharma Innovation Bond to Accelerate R&D
Shanghai-based Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has successfully issued the nation’s first...